26O Phase I dose-escalation trial with tumor-targeted interleukin-12 (IL12-L19L19) in patients with solid tumors
| Autor: | Curigliano, G., Belli, C., Colombo, I., Ziemer, M., Schmid, S., Dakhel, S., Puca, E., Mulatto, S., Hemmerle, T., Mock, J.C., Lorizzo, K., Neri, D., Covelli, A., Simon, J-C., Lauer, U., Läubli, H., Hassel, J.C., Stathis, A., Fiedler, W.M., Mach, N. |
|---|---|
| Zdroj: | In ESMO Open February 2024 9 Supplement 1 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|